Milestone Pharmaceuticals, Inc. (MIST)
0.8097
-0.01
(-0.74%)
USD |
NASDAQ |
Oct 02, 16:00
0.8036
-0.01
(-0.75%)
After-Hours: 20:00
Milestone Pharmaceuticals Cash from Operations (TTM) : -60.75M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -60.75M |
| March 31, 2026 | -51.25M |
| December 31, 2025 | -49.14M |
| September 30, 2025 | -43.14M |
| June 30, 2025 | -40.34M |
| March 31, 2025 | -33.25M |
| December 31, 2024 | -28.23M |
| September 30, 2024 | -31.14M |
| June 30, 2024 | -36.33M |
| March 31, 2024 | -41.03M |
| December 31, 2023 | -46.00M |
| September 30, 2023 | -48.19M |
| June 30, 2023 | -46.95M |
| March 31, 2023 | -50.27M |
| Date | Value |
|---|---|
| December 31, 2022 | -50.31M |
| September 30, 2022 | -51.19M |
| June 30, 2022 | -49.33M |
| March 31, 2022 | -34.52M |
| December 31, 2021 | -33.04M |
| September 30, 2021 | -30.43M |
| June 30, 2021 | -29.72M |
| March 31, 2021 | -46.61M |
| December 31, 2020 | -52.22M |
| September 30, 2020 | -59.15M |
| June 30, 2020 | -59.39M |
| March 31, 2020 | -54.76M |
| December 31, 2019 | -51.42M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| NervGen Pharma Corp. | -18.43M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.426M |
| Target Group, Inc. (Canada) | -1.073M |